Ozempic vs. Rybelsus (Now the Ozempic Pill): Injection vs. Daily Tablet
See how Ozempic and Rybelsus compare on approved uses, dosing, side effects, and cost. In the US, Rybelsus is now sold as the Ozempic pill (same active ingredient, new 1.5, 4 and 9 mg strengths).
Medically reviewed by Veronica Hackethal | MD, MSc, Harvard University | University of Oxford | Columbia Vagelos College of Physicians and Surgeons on September 8, 2026.
Key Takeaways
Ozempic and Rybelsus both contain semaglutide: Ozempic is a weekly injection, and Rybelsus is the daily pill, now sold in the US as the Ozempic pill (1.5, 4 and 9 mg tablets).
Both are FDA-approved for type 2 diabetes and for lowering cardiovascular risk, and Ozempic also slows kidney disease in type 2 diabetes; neither is approved for weight loss.
The Ozempic pill must be taken on an empty stomach with up to 4 ounces of plain water, then no food, drinks or other pills for 30 minutes, while Ozempic has no such timing rules.
Ozempic vs. Rybelsus at a Glance
Ozempic
Ozempic pill (formerly Rybelsus)
| FEATURE | OZEMPIC |
| Form | Weekly injection |
| US brand status 2026 | Sold as Ozempic |
| Dose strengths | 0.25, 0.5, 1 and 2 mg once weekly |
| Approved uses | Type 2 diabetes, cardiovascular risk, kidney disease in type 2 diabetes |
| Food and water rules | None |
| 2026 self-pay cost | $350 a month via TrumpRx |
| FEATURE | OZEMPIC PILL (FORMERLY RYBELSUS) |
| Form | Daily tablet |
| US brand status 2026 | Rybelsus renamed the Ozempic pill (launched May 4, 2026) |
| Dose strengths | 1.5, 4 and 9 mg once daily |
| Approved uses | Type 2 diabetes, cardiovascular risk in high-risk adults |
| Food and water rules | Empty stomach, up to 4 oz plain water, then wait 30 minutes |
| 2026 self-pay cost | $149 to $299 a month at launch, by strength |
Ozempic
| FEATURE | OZEMPIC |
| Form | Weekly injection |
| US brand status 2026 | Sold as Ozempic |
| Dose strengths | 0.25, 0.5, 1 and 2 mg once weekly |
| Approved uses | Type 2 diabetes, cardiovascular risk, kidney disease in type 2 diabetes |
| Food and water rules | None |
| 2026 self-pay cost | $350 a month via TrumpRx |
Ozempic pill (formerly Rybelsus)
| FEATURE | OZEMPIC PILL (FORMERLY RYBELSUS) |
| Form | Daily tablet |
| US brand status 2026 | Rybelsus renamed the Ozempic pill (launched May 4, 2026) |
| Dose strengths | 1.5, 4 and 9 mg once daily |
| Approved uses | Type 2 diabetes, cardiovascular risk in high-risk adults |
| Food and water rules | Empty stomach, up to 4 oz plain water, then wait 30 minutes |
| 2026 self-pay cost | $149 to $299 a month at launch, by strength |
Ozempic vs. the Ozempic Pill (Formerly Rybelsus): How They Differ
Ozempic
Ozempic is a GLP-1 receptor agonist that helps adults with type 2 diabetes manage blood sugar, and it also lowers cardiovascular and kidney risk in people with existing heart or kidney disease. It's given as a subcutaneous injection once a week, starting at a low dose and increasing gradually. Many people also use it off-label for weight loss. For full dosing and safety details, see the Ozempic medication guide.
Ozempic pill (formerly Rybelsus)
The Ozempic pill (oral semaglutide, sold as Rybelsus until 2026) is a once-daily GLP-1 tablet for type 2 diabetes that also lowers cardiovascular risk in high-risk adults. In the US it now comes in 1.5 mg, 4 mg and 9 mg strengths, which replaced Rybelsus 3, 7 and 14 mg. It is not approved for weight loss; the Wegovy pill is the oral semaglutide for weight management.
The FDA approved the new name and strengths on February 4, 2026. The pill launched May 4, 2026, and Rybelsus shipments stopped that month. Outside the US, it's still sold as Rybelsus.
The old and new strengths roughly match, but they aren't mg-for-mg interchangeable, so switch only with a licensed doctor. For more on the two forms, see oral vs injectable semaglutide.
Ozempic vs. Rybelsus Side Effects
Ozempic
Ozempic pill (formerly Rybelsus)
Ozempic vs. Rybelsus Dosage
Ozempic
Ozempic pill (formerly Rybelsus)
| STAGE | DOSE | WHEN |
| Starting dose | 0.25 mg once weekly | Weeks 1-4 |
| Maximum dose | 2 mg once weekly | Week 13 onward |
| Dose changes | 3 increases (0.5, 1, then 2 mg) | Every 4 weeks or more |
| STAGE | DOSE | WHEN |
| Starting dose | 1.5 mg once daily (old Rybelsus 3 mg) | Days 1-30 |
| Maximum dose | 9 mg once daily (old Rybelsus 14 mg) | Day 61 onward |
| Dose changes | 2 increases (4 mg, then 9 mg) | After 30 days; 9 mg only if needed |
Ozempic
| STAGE | DOSE | WHEN |
| Starting dose | 0.25 mg once weekly | Weeks 1-4 |
| Maximum dose | 2 mg once weekly | Week 13 onward |
| Dose changes | 3 increases (0.5, 1, then 2 mg) | Every 4 weeks or more |
Ozempic pill (formerly Rybelsus)
| STAGE | DOSE | WHEN |
| Starting dose | 1.5 mg once daily (old Rybelsus 3 mg) | Days 1-30 |
| Maximum dose | 9 mg once daily (old Rybelsus 14 mg) | Day 61 onward |
| Dose changes | 2 increases (4 mg, then 9 mg) | After 30 days; 9 mg only if needed |
Ozempic vs. Rybelsus Indications
Ozempic
Ozempic is approved to improve blood sugar control in adults with type 2 diabetes alongside diet and exercise. It also carries approvals to reduce major cardiovascular events in adults with type 2 diabetes and known heart disease, and to slow kidney damage progression in those with chronic kidney disease and type 2 diabetes. It is not approved for weight loss or type 1 diabetes.
Blood sugar control in type 2 diabetes
Lowers risk of heart attack, stroke, death in heart disease
Slows kidney damage progression in chronic kidney disease
Not approved for weight loss (Wegovy holds that indication)
Ozempic pill (formerly Rybelsus)
The Ozempic pill is approved to improve blood sugar control in adults with type 2 diabetes. In October 2025, the FDA expanded its label to include reducing major cardiovascular events in high-risk adults with type 2 diabetes, based on the SOUL trial (a 14% relative risk reduction). It was the first GLP-1 pill approved to lower cardiovascular risk. It is not approved for weight loss or type 1 diabetes: the Wegovy pill (oral semaglutide 25 mg, approved December 22, 2025) is the oral semaglutide approved for weight management.
Blood sugar control in type 2 diabetes
Lowers cardiovascular risk in high-risk adults (added 2025)
Not approved for weight loss or type 1 diabetes
The Ozempic pill (formerly Rybelsus) is the only GLP-1 pill approved for type 2 diabetes; the Wegovy pill and Foundayo are GLP-1 pills approved for weight management
Ozempic vs. Ozempic Pill Pros, Cons and Cost
Ozempic
Ozempic carries more FDA-approved uses than the Ozempic pill, including slowing kidney disease progression, and its weekly injection means fewer doses to remember. It has no food or water timing restrictions around dosing. Coverage varies by plan, especially for off-label weight loss use. Ozempic self-pay is $350 a month via TrumpRx, per the White House. If it fits, you can get Ozempic online after a video visit with a licensed doctor.
Pros
Additional FDA approval for slowing kidney disease progression
Only one dose per week instead of a daily routine
No food or water timing restrictions around dosing
Cons
Requires self-injection, which some people avoid
Needle disposal and injection site rotation needed
Injection site reactions are possible
Ozempic pill (formerly Rybelsus)
The Ozempic pill offers the same active ingredient as Ozempic in pill form for people who prefer to avoid injections. It requires taking the tablet on an empty stomach with up to 4 ounces of plain water, then waiting 30 minutes before eating, drinking, or taking other medications. Its cardiovascular risk-reduction approval is newer, added in October 2025. If you already take it, you can refill the Ozempic pill online after a licensed doctor reviews your history.
Pros
No injections or needles required
Easier option for people uncomfortable with self-injection
No needle disposal to manage
Launch self-pay prices: $149 (1.5 mg), $199 (4 mg) and $299 (9 mg) a month
Cons
Must be taken on an empty stomach with strict timing
Cannot take other oral meds within 30 minutes of dosing
Newer cardiovascular approval with less real-world data
Frequently Asked Questions
The new name and switching
Is Rybelsus now called the Ozempic pill?
Yes, in the US. It's the same medicine, oral semaglutide, in the new 1.5, 4 and 9 mg strengths; the Rybelsus name continues outside the US. If you take Rybelsus now, a licensed doctor decides when and how you switch. For how it compares with the shot, see Rybelsus vs Ozempic differences.
Can I switch from Rybelsus 14 mg to the Ozempic pill or to Ozempic injections?
Yes, with a licensed doctor. Rybelsus 14 mg roughly lines up with the 9 mg Ozempic pill, but the strengths aren't mg-for-mg interchangeable, and moving to the weekly injection means a new dose plan. Your doctor sets the dose and timing with you; don't combine the pill and the shot on your own.
Weight loss
Is the Ozempic pill approved for weight loss?
No. It treats type 2 diabetes and lowers cardiovascular risk. The GLP-1 pills approved for weight management are the Wegovy pill and Foundayo (see Foundayo vs Rybelsus), and a licensed doctor can help you decide whether starting or switching fits you.
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.